Abstract: The present disclosure provides methods and systems directed to cell-free identification and/or monitoring of pregnancy-related states. A method for identifying or monitoring a presence or elevated risk of a pregnancy-related state of a pregnant subject may comprise assaying a cell-free biological sample derived from said pregnant subject to detect a set of biomarkers, and analyzing the set of biomarkers with a trained algorithm to determine the presence or elevated risk of the pregnancy-related state.

Abstract: Methods and systems may perform cell-free identification and/or monitoring of pregnancy-related states. A method for identifying or monitoring a presence or susceptibility of a pregnancy-related state of a subject may comprise assaying a cell-free biological sample derived from the subject to detect a set of biomarkers, and analyzing the set of biomarkers with a trained algorithm to determine the presence or susceptibility of the pregnancy-related state.

Abstract: Methods and systems may perform cell-free identification and/or monitoring of pregnancy-related states. A method for identifying or monitoring a presence or susceptibility of a pregnancy-related state of a subject may comprise assaying a cell-free biological sample derived from the subject to detect a set of biomarkers, and analyzing the set of biomarkers with a trained algorithm to determine the presence or susceptibility of the pregnancy-related state.

Abstract: Methods and systems may perform cell-free identification and/or monitoring of pregnancy-related states. A method for identifying or monitoring a presence or susceptibility of a pregnancy-related state of a subject may comprise assaying a cell-free biological sample derived from the subject to detect a set of biomarkers, and analyzing the set of biomarkers with a trained algorithm to determine the presence or susceptibility of the pregnancy-related state.

Abstract: The present disclosure provides methods and systems directed to cell-free identification and/or monitoring of pregnancy-related states. A method for identifying or monitoring a presence or susceptibility of a pregnancy-related state of a subject may comprise assaying a cell-free biological sample derived from said subject to detect a set of biomarkers, and analyzing the set of biomarkers with a trained algorithm to determine the presence or susceptibility of the pregnancy-related state.

Abstract: Methods and systems may perform cell-free identification and/or monitoring of pregnancy-related states. A method for identifying or monitoring a presence or susceptibility of a pregnancy-related state of a subject may comprise assaying a cell-free biological sample derived from the subject to detect a set of biomarkers, and analyzing the set of biomarkers with a trained algorithm to determine the presence or susceptibility of the pregnancy-related state.

Abstract: Methods and systems may perform cell-free identification and/or monitoring of pregnancy-related states. A method for identifying or monitoring a presence or susceptibility of a pregnancy-related state of a subject may comprise assaying a cell-free biological sample derived from the subject to detect a set of biomarkers, and analyzing the set of biomarkers with a trained algorithm to determine the presence or susceptibility of the pregnancy-related state.

Abstract: Methods and systems may perform cell-free identification and/or monitoring of pregnancy-related states. A method for identifying or monitoring a presence or susceptibility of a pregnancy-related state of a subject may comprise assaying a cell-free biological sample derived from the subject to detect a set of biomarkers, and analyzing the set of biomarkers with a trained algorithm to determine the presence or susceptibility of the pregnancy-related state.

Abstract: The present disclosure provides methods and systems directed to cell-free identification and/or monitoring of pregnancy-related states. A method for identifying or monitoring a presence or susceptibility of a pregnancy-related state of a subject may comprise assaying a cell-free biological sample derived from said subject to detect a set of biomarkers, and analyzing the set of biomarkers with a trained algorithm to determine the presence or susceptibility of the pregnancy-related state.

Abstract: The present disclosure provides methods and systems directed to cell-free identification and/or monitoring of pregnancy-related states. A method for identifying or monitoring a presence or susceptibility of a pregnancy-related state of a subject may comprise assaying a cell-free biological sample derived from said subject to detect a set of biomarkers, and analyzing the set of biomarkers with a trained algorithm to determine the presence or susceptibility of the pregnancy-related state.

Abstract: The present disclosure provides methods and systems directed to cell-free identification and/or monitoring of pregnancy-related states. A method for identifying or monitoring a presence or susceptibility of a pregnancy-related state of a subject may comprise assaying a cell-free biological sample derived from said subject to detect a set of biomarkers, and analyzing the set of biomarkers with a trained algorithm to determine the presence or susceptibility of the pregnancy-related state.

Abstract: The fuel quality sensor includes two rectangular parallepiped waveguides of equal dimensions stacked one atop the other and having a common ground. A thin wire extends through the intermediate wall(s) between the upper and lower waveguide cavities. An input connector is mounted on a sidewall of the upper waveguide, and an output connector is mounted on a sidewall of the lower waveguide cavity. A fluid conduit extends through the upper waveguide cavity adjacent the wire. A tunable microwave signal or wideband time domain pulse is applied to the input connector while fuel is flowing through the conduit. If the fuel flowing in the conduit is uncontaminated, the output signal at the second connector will show no change from the tunneling frequency, but if the fuel is contaminated, the change in the fuel's dielectric constant will result in a change in tunneling frequency and/or tan ? at the second connector.

Abstract: The fuel quality sensor includes two rectangular parallepiped waveguides of equal dimensions stacked one atop the other and having a common ground. A thin wire extends through the intermediate wall(s) between the upper and lower waveguide cavities. An input connector is mounted on a sidewall of the upper waveguide, and an output connector is mounted on a sidewall of the lower waveguide cavity. A fluid conduit extends through the upper waveguide cavity adjacent the wire. A tunable microwave signal or wideband time domain pulse is applied to the input connector while fuel is flowing through the conduit. If the fuel flowing in the conduit is uncontaminated, the output signal at the second connector will show no change from the tunneling frequency, but if the fuel is contaminated, the change in the fuel's dielectric constant will result in a change in tunneling frequency and/or tan ? at the second connector.

Abstract: The microstrip Fano resonator switch is a microstrip circuit having a varactor diode electrically connected between identical quarter-wavelength open stubs formed from two elongate planar strip elements disposed on a substrate having a permittivity of approximately 2.94 and a thickness of approximately 0.76 mm, the circuit forming a Fano resonator switch that provides approximately 50 dB of isolation.

Abstract: The microstrip circuits exhibiting electromagnetically induced transparency and Fano resonance include a microstrip transmission line and at least two identical parallel quarter-wavelength open stubs extending from the transmission line in close proximity so that mutual coupling between the electromagnetic fields at adjacent ends of the stubs induces Faro resonances and electromagnetically induced transparency (EIT). The circuits may be used for microwave buffers, or when a variable capacitance, such as a varactor, is inserted between the open ends of the stubs, the circuits may be used for active transmission phase control.

Abstract: Methods and systems for array-based methods for genotyping multiallelic markers are disclosed. Also disclosed herein are methods for whole genome amplification and locus specific multiplex PCR for selectively biasing amplification for reducing effects of undesired pseudogenes in resulting data.

Abstract: The microstrip Fano resonator switch is a microstrip circuit having a varactor diode electrically connected between identical quarter-wavelength open stubs formed from two elongate planar strip elements disposed on a substrate having a permittivity of approximately 2.94 and a thickness of approximately 0.76 mm, the circuit forming a Fano resonator switch that provides approximately 50 dB of isolation.

Abstract: The microstrip circuits exhibiting electromagnetically induced transparency and Fano resonance include a microstrip transmission line and at least two identical parallel quarter-wavelength open stubs extending from the transmission line in close proximity so that mutual coupling between the electromagnetic fields at adjacent ends of the stubs induces Faro resonances and electromagnetically induced transparency (EIT). The circuits may be used for microwave buffers, or when a variable capacitance, such as a varactor, is inserted between the open ends of the stubs, the circuits may be used for active transmission phase control.